Edition:
United Kingdom

UK SMALL CAPS Report Headlines

GlaxoSmithKline adult shingles vaccine wins U.S. approval

The U.S. Food and Drug Administration approved GlaxoSmithKline's Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected after an advisory panel to the agency last month voted unanimously to recommend its approval, the company announced on Friday.

UPDATE 3-Acacia-Tanzania proposed settlement on track -Barrick

Barrick Gold said on Friday a proposed mining settlement it negotiated with Tanzania for its Acacia Mining unit was not under threat, even though Acacia said it could not immediately make a $300 million payment included in the deal. Barrick, which owns 63.9 percent of